GlassScriptPhysician profile
Scott Raymond Luallin
NPI 1114919982
$21,338.00
in general payments reported to CMS, 2019-2025
11 companies · $1,794 in 2025
The $1,794 reported for 2025 was more than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
See the full distribution for Sports Medicine (Orthopaedic Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $732 · 2020: $6,480 · 2021: $7,302 · 2022: $2,757 · 2023: $1,619 · 2024: $654 · 2025: $1,794.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,538 · Consulting Fee: $1,375 · Travel and Lodging: $921 · Education: $234.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,538.08 |
| Consulting Fee | $1,375.00 |
| Travel and Lodging | $920.74 |
| Education | $233.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vericel Corporation | $9,074.14 | 2019-2025 | Maci |
| Titan Surgical Group, LLC | $6,999.63 | 2019-2024 | |
| Zimmer Biomet Holdings, INC. | $2,429.35 | 2019-2025 | Oxford |
| Arthrex, INC. | $1,557.68 | 2022 | |
| Stryker Corporation | $650.61 | 2021-2025 | Blueprint Patient Specific Instrumentation, Reunion, Aequalis Perform+ |
| Smith+Nephew, INC. | $370.56 | 2019-2025 | Bone Anchors With Arthroscopic Delivery System, Bioinductive Implant With Arthroscopic Delivery System - Medium, Pico 14 |
| Anika Therapeutics, INC. | $170.84 | 2025 | Integrity Implant |
| Depuy Synthes Sales INC. | $34.14 | 2025 | Lcp |
| Joint Restoration Foundation, INC. | $29.18 | 2019 | |
| Convatec INC. | $21.87 | 2025 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$6,173,655.03 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Luallin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.